Literature DB >> 31136707

A Mn(III)-Sealed Metal-Organic Framework Nanosystem for Redox-Unlocked Tumor Theranostics.

Shuang-Shuang Wan1, Qian Cheng1, Xuan Zeng1, Xian-Zheng Zhang1.   

Abstract

Here, a Mn(III)-sealed metal-organic framework (MOF) nanosystem based on coordination between Mn(III) and porphyrin (TCPP) via a one-pot method was designed and constructed. Mn(III), as a sealer, not only quenched TCPP-based fluorescence but also inhibited reactive oxygen species (ROS) generation, which made MOFs an "inert" theranostic nanoparticle. Interestingly, upon endocytosis by tumor cells, MOFs were disintegrated into Mn(II) and free TCPP by intracellular glutathione (GSH) in tumor cells, owing to redox reaction between Mn(III) and GSH. This disintegration would lead to consumption of antioxidant GSH and activated Mn(II)-based magnetic resonance imaging (MRI) as well as TCPP-based fluorescent imaging. More importantly, such a GSH-regulated TCPP release could implement controllable ROS generation under irradiation, which avoided side effects (inflammation and damage of normal tissues). As a consequence, after unlocking by GSH, Mn(III)-sealed MOFs could significantly improve the therapeutic efficiency of photodynamic therapy by combining controlled ROS generation and GSH depletion after precise dual tumor homing.

Entities:  

Keywords:  GSH depletion; GSH-activated imaging; controllable ROS generation; metal−organic framework; tumor theranostics

Year:  2019        PMID: 31136707     DOI: 10.1021/acsnano.9b00300

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  20 in total

Review 1.  A promising anticancer drug: a photosensitizer based on the porphyrin skeleton.

Authors:  Qizhi Zhang; Jun He; Wenmei Yu; Yanchun Li; Zhenhua Liu; Binning Zhou; Yunmei Liu
Journal:  RSC Med Chem       Date:  2020-02-25

Review 2.  Bioengineering of nano metal-organic frameworks for cancer immunotherapy.

Authors:  Gaowei Chong; Jie Zang; Yi Han; Runping Su; Nopphon Weeranoppanant; Haiqing Dong; Yongyong Li
Journal:  Nano Res       Date:  2020-11-23       Impact factor: 8.897

3.  Impact of particle size and pH on protein corona formation of solid lipid nanoparticles: A proof-of-concept study.

Authors:  Wenhao Wang; Zhengwei Huang; Yanbei Li; Wenhua Wang; Jiayu Shi; Fangqin Fu; Ying Huang; Xin Pan; Chuanbin Wu
Journal:  Acta Pharm Sin B       Date:  2020-10-29       Impact factor: 11.413

4.  Recent advances in porous nanostructures for cancer theranostics.

Authors:  Jinping Wang; Beilu Zhang; Jingyu Sun; Wei Hu; Hongjun Wang
Journal:  Nano Today       Date:  2021-04-08       Impact factor: 18.962

5.  Eradication of solid tumors by chemodynamic theranostics with H2O2-catalyzed hydroxyl radical burst.

Authors:  Nana Wang; Qin Zeng; Ruijing Zhang; Da Xing; Tao Zhang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 6.  Activatable Nanoparticles: Recent Advances in Redox-Sensitive Magnetic Resonance Contrast Agent Candidates Capable of Detecting Inflammation.

Authors:  Chukwuazam Nwasike; Erin Purr; Eunsoo Yoo; Jaspreet Singh Nagi; Amber L Doiron
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-16

Review 7.  Porphyrin-Based Metal-Organic Frameworks for Biomedical Applications.

Authors:  Jiajie Chen; Yufang Zhu; Stefan Kaskel
Journal:  Angew Chem Int Ed Engl       Date:  2020-10-12       Impact factor: 15.336

8.  Reactive oxygen species (ROS)-responsive nanoprobe for bioimaging and targeting therapy of osteoarthritis.

Authors:  Chong Shen; Ming Gao; Haimin Chen; Yanting Zhan; Qiumei Lan; Zhimin Li; Wei Xiong; Zainen Qin; Li Zheng; Jinmin Zhao
Journal:  J Nanobiotechnology       Date:  2021-11-27       Impact factor: 10.435

9.  Carbon-Coated Magnetic Nanoparticle Dedicated to MRI/Photoacoustic Imaging of Tumor in Living Mice.

Authors:  Yujing Li; Fei Ye; Shanxiang Zhang; Wenjun Ni; Liewei Wen; Huan Qin
Journal:  Front Bioeng Biotechnol       Date:  2021-12-02

10.  Regulation of redox balance using a biocompatible nanoplatform enhances phototherapy efficacy and suppresses tumor metastasis.

Authors:  Qunying Jiang; Min Pan; Jialing Hu; Junlin Sun; Lei Fan; Zhiqiao Zou; Jianshuang Wei; Xiaoquan Yang; Xiaoqing Liu
Journal:  Chem Sci       Date:  2020-10-22       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.